Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/18/7/1165/643138/mdm119.pdf
Reference38 articles.
1. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer;Hillner;J Clin Oncol,2003
2. Bisphosphonates for malignancy-related bone disease: current status, future developments;Body;Support Care Cancer,2006
3. Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases;Body;Ann Oncol,2003
4. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer;Body;Pain,2004
5. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo controlled trials;Lipton;Cancer,2000
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Preventive Effect of Preoperative and Postoperative Selenium on the Medication-Related Osteonecrosis of the Jaw: An Animal Study in Rats;Journal of Oral and Maxillofacial Surgery;2024-07
2. Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis;Journal of Clinical Medicine;2021-11-20
3. Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody;Cancer Treatment Reviews;2019-06
4. Toxicity of Bone-Targeted Agents in Malignancy;Side Effects of Medical Cancer Therapy;2018
5. Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks;Vnitřní lékařství;2017-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3